Plasminogen Is a Critical Host Pathogenicity Factor for Group A Streptococcal Infection
Top Cited Papers
- 27 August 2004
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 305 (5688) , 1283-1286
- https://doi.org/10.1126/science.1101245
Abstract
Group A streptococci, a common human pathogen, secrete streptokinase, which activates the host's blood clot–dissolving protein, plasminogen. Streptokinase is highly specific for human plasminogen, exhibiting little or no activity against other mammalian species, including mouse. Here, a transgene expressing human plasminogen markedly increased mortality in mice infected with streptococci, and this susceptibility was dependent on bacterial streptokinase expression. Thus, streptokinase is a key pathogenicity factor and the primary determinant of host species specificity for group A streptococcal infection. In addition, local fibrin clot formation may be implicated in host defense against microbial pathogens.Keywords
This publication has 24 references indexed in Scilit:
- M Protein, a Classical Bacterial Virulence Determinant, Forms Complexes with Fibrinogen that Induce Vascular LeakageCell, 2004
- Plasminogen Enhances Virulence of Group A Streptococci by Streptokinase‐Dependent and Streptokinase‐Independent MechanismsThe Journal of Infectious Diseases, 2003
- CD46 in Meningococcal DiseaseScience, 2003
- Bacterial plasminogen activators and receptorsFEMS Microbiology Reviews, 2001
- EditorialMethods, 2000
- Interaction between Group A Streptococci and the Plasmin(ogen) System Promotes Virulence in a Mouse Skin Infection ModelThe Journal of Infectious Diseases, 1999
- Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.Genes & Development, 1995
- Characterization of the Murine Plasma Fibrinolytic SystemEuropean Journal of Biochemistry, 1994
- Streptokinases Produced by Pathogenic Group C Streptococci Demonstrate Species-Specific Plasminogen ActivationThe Journal of Infectious Diseases, 1991
- Possible pathway for formation of fibrin degradation products during ancrod therapyNature, 1975